FOR PATIENTS

Dreading the prep? There's a better way.

ZeraFlow is a staff-supervised, about 30-minute in-clinic experience, designed as an alternative to traditional at-home bowel prep. Just three mild laxative tablets the night before. No liquid prep solution. No guesswork. Just show up.

YOU ARE NOT ALONE

You’re Not the Problem. The prep is.

71%

of colonoscopy patients say the prep is the worst part of the entire experience. ¹

40%+

of eligible adults are not up to date on recommended colorectal cancer screenings.

Millions

of screenings are missed every year - not because of the procedure, but what comes before it.

This isn't a patient problem. It's a system design problem. ZeraFlow was built to change that.

What about privacy?

ZeraFlow is performed in a private room with a dedicated staff member. The process is designed to be gentle, private, and supervised from start to finish — and over in about 30 minutes, after which you go straight into your colonoscopy.

Three steps. That is all.

  • Take your tablets (the night before)

    Three mild laxative tablets the night before. No liquid prep. Follow your clinic's dietary instructions. Just a light dinner.

  • Arrive at your clinic

    Come in the morning of your colonoscopy as you normally would. Your care team takes it from here.

  • Complete your ZeraFlow prep

    Designed to complete prep in about 30 minutes before your procedure begins.

THE DIFFERENCE

Traditional prep vs. ZeraFlow

Traditional oral prep
ZeraFlow
At home, alone
At the clinic, staff-supervised
Up to 24-hour home prep
About 30 minutes
Liters of liquid to drink
No large-volume liquid prep at home
Nausea, bloating, disrupted sleep
Warm water, minimal discomfort
Uncertain whether it worked
Confirmed ready before the scope begins

ZeraFlow is not available everywhere yet.

We are completing FDA clearance and selecting our first U.S. clinic partners. Enter your information and we will notify you as soon as ZeraFlow is available near you.

¹Gimeno-Garcia AZ et al. Gastroenterology. 2022. PubMed ID: 35324481.
² McLachlan SA, Clements A, Austoker J. Patients’ experiences and reported barriers to screening colonoscopy: A systematic review. Journal of Clinical Oncology. 2009;27(Suppl):S15.
³McLachlan SA, Clements A, Austoker J. Patients' experiences and reported barriers to colonoscopy: a systematic review. Journal of Clinical Oncology. 2009;27(Suppl):S15. https://pubmed.ncbi.nlm.nih.gov/21640543/
ZeraFlow is an investigational device. It has not been cleared or approved by the U.S. FDA and is not currently available for commercial sale in the United States.